Preconditioning and postconditioning: the essential role of the mitochondrial permeability transition pore
- PMID: 17512507
- PMCID: PMC2080572
- DOI: 10.1016/j.cardiores.2007.04.022
Preconditioning and postconditioning: the essential role of the mitochondrial permeability transition pore
Abstract
Objective: The opening of the mitochondrial permeability transition pore (mPTP) at the time of myocardial reperfusion is a critical determinant of cell death. Emerging studies suggest that suppression of mPTP opening may underlie the cardioprotection elicited by both ischemic preconditioning (IPC) and postconditioning (IPost). To further evaluate the role of the mPTP in cardioprotection, we hypothesized that hearts deficient in cyclophilin-D (CYP-D-/-), a key component of the mPTP, will be resistant to cardioprotection conferred by ischemic and pharmacological preconditioning and postconditioning.
Methods and results: Male/female wild type or CYP-D-/- mice were subjected to 30 min of ischemia and 120 min of reperfusion. In wild type mice subjected to in vivo myocardial ischemia-reperfusion injury, a significant reduction in myocardial infarct size was observed with the following treatments (n>/=6/group; P<0.05): (1) IPC (28+/-4% vs. 46.2+/-4% in control); (2) Diazoxide (5 mg/kg) pre-treatment (26.4+/-3% vs. 54+/-10% in vehicle control); (3) IPost-1 or IPost-2, three or six 10-s cycles of ischemia-reperfusion (27.2+/-3% and 32+/-4%, respectively vs. 46.2+/-4% in control); (4) Bradykinin (40 mug/kg) (28.3+/-1% vs. 48+/-4% in vehicle control); (5) cyclosporin-A (10 mg/kg) (32.3+/-3% vs. 48+/-4% in vehicle control) (6) sanglifehrin-A (25 mg/kg) (29.3+/-3% vs. 48+/-4% in vehicle control). Interestingly, however, no infarct-limiting effects were demonstrated in CYP-D-/- mice with the same treatment protocols: (27.9+/-5% in control vs. 31.2+/-7% with IPC, 30.2+/-5% with IPost-1, 24.7+/-8% with IPost-2; 30.1+/-4% in vehicle control vs. 26.4+/-7% with diazoxide; 24.6+/-4% in vehicle control vs. 24.9+/-5% with bradykinin, 26.8+/-7% with cyclosporin-A, 32.5+/-6% with sanglifehrin-A: n>/=6/group: P>0.05).
Conclusion: This study demonstrates that the mPTP plays a critical role in the cardioprotection elicited by ischemic and pharmacological preconditioning and postconditioning.
Figures
![Fig. 1](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/2080572/bin/nihms-1159-f0001.gif)
![Fig. 2](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/2080572/bin/nihms-1159-f0002.gif)
![Fig. 3](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/2080572/bin/nihms-1159-f0003.gif)
![Fig. 4](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/2080572/bin/nihms-1159-f0004.gif)
Similar articles
-
Inhibiting mitochondrial permeability transition pore opening: a new paradigm for myocardial preconditioning?Cardiovasc Res. 2002 Aug 15;55(3):534-43. doi: 10.1016/s0008-6363(02)00455-8. Cardiovasc Res. 2002. PMID: 12160950
-
Transient mitochondrial permeability transition pore opening mediates preconditioning-induced protection.Circulation. 2004 Apr 13;109(14):1714-7. doi: 10.1161/01.CIR.0000126294.81407.7D. Epub 2004 Apr 5. Circulation. 2004. PMID: 15066952
-
Increased mitochondrial calcium coexists with decreased reperfusion injury in postconditioned (but not preconditioned) hearts.Am J Physiol Heart Circ Physiol. 2008 Jan;294(1):H386-91. doi: 10.1152/ajpheart.01035.2007. Epub 2007 Oct 19. Am J Physiol Heart Circ Physiol. 2008. PMID: 17951363
-
The mitochondrial permeability transition pore as a target for preconditioning and postconditioning.Basic Res Cardiol. 2009 Mar;104(2):189-202. doi: 10.1007/s00395-009-0010-x. Epub 2009 Feb 26. Basic Res Cardiol. 2009. PMID: 19242644 Review.
-
Mitochondrial permeability transition pore and postconditioning.Cardiovasc Res. 2006 May 1;70(2):264-73. doi: 10.1016/j.cardiores.2006.02.024. Epub 2006 Feb 28. Cardiovasc Res. 2006. PMID: 16581044 Review.
Cited by
-
The RISK pathway leading to mitochondria and cardioprotection: how everything started.Basic Res Cardiol. 2023 May 26;118(1):22. doi: 10.1007/s00395-023-00992-5. Basic Res Cardiol. 2023. PMID: 37233787 Free PMC article. Review.
-
Mitochondria-associated endoplasmic reticulum membranes (MAMs): Possible therapeutic targets in heart failure.Front Cardiovasc Med. 2023 Jan 26;10:1083935. doi: 10.3389/fcvm.2023.1083935. eCollection 2023. Front Cardiovasc Med. 2023. PMID: 36776252 Free PMC article. Review.
-
Genetic Inhibition of Mitochondrial Permeability Transition Pore Exacerbates Ryanodine Receptor 2 Dysfunction in Arrhythmic Disease.Cells. 2023 Jan 4;12(2):204. doi: 10.3390/cells12020204. Cells. 2023. PMID: 36672139 Free PMC article.
-
Ischemic Preconditioning and Postconditioning Protect the Heart by Preserving the Mitochondrial Network.Biomed Res Int. 2022 Sep 27;2022:6889278. doi: 10.1155/2022/6889278. eCollection 2022. Biomed Res Int. 2022. PMID: 36203484 Free PMC article.
-
The effect of Cyclophilin D depletion on liver regeneration following associating liver partition and portal vein ligation for staged hepatectomy.PLoS One. 2022 Jul 14;17(7):e0271606. doi: 10.1371/journal.pone.0271606. eCollection 2022. PLoS One. 2022. PMID: 35834573 Free PMC article.
References
-
- Murry CE, Jennings RB, Reimer KA. Preconditioning with ischemia: a delay of lethal cell injury in ischemic myocardium. Circulation. 1986;74:1124–36. - PubMed
-
- Zhao ZQ, Corvera JS, Halkos ME, Kerendi F, Wang NP, Guyton RA, et al. Inhibition of myocardial injury by ischemic postconditioning during reperfusion: comparison with ischemic preconditioning. Am J Physiol Heart Circ Physiol. 2003;285:H579–88. - PubMed
-
- Staat P, Rioufol G, Piot C, Cottin Y, Cung TT, L’Huillier I, et al. Postconditioning the human heart. Circulation. 2005;112:2143–8. - PubMed
-
- Hausenloy DJ, Duchen MR, Yellon DM. Inhibiting mitochondrial permeability transition pore opening at reperfusion protects against ischaemia-reperfusion injury. Cardiovasc Res. 2003;60:617–25. - PubMed